Pharmaceutical News

RSS

New study shows low doses of aspirin can significantly reduce risk of cancers

A new study by scientists from Oxford, Edinburgh, London and Japan shows that at low doses, aspirin can significantly reduce the risk of a range of cancers.

20 Feb 2011

QRxPharma granted FDA pre-NDA meeting, further phase II data released

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the granting of a pre-New Drug Application (NDA) meeting with the United States Food and Drug Administration (FDA) and successful completion of its third pivotal Phase 3 registration trial (study 009) for immediate-release MoxDuo.

20 Feb 2011

PBMI awards CVS Caremark and ArcelorMittal the 2011 Rx Benefit Innovation Award

CVS Caremark announced today that the Pharmacy Benefit Management Institute (PBMI) awarded the company and its PBM client ArcelorMittal, the world's largest steel company, the 2011 Rx Benefit Innovation Award. The award recognizes the Pharmacy Advisor program, which was developed by CVS Caremark to manage costs, improve medication adherence and close gaps in care for members with diabetes.

19 Feb 2011

Upsher-Smith expands voluntary recall of Jantoven Warfarin Sodium, 3 mg Tablets

Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010.

19 Feb 2011

U.S. scientists assess progress of dengue vaccine at 3-day summit in Puerto Rico

During a meeting in Puerto Rico on Thursday to discuss recent progress towards fighting dengue, researchers voiced optimism over advances in the development of vaccines to prevent the spread of the virus, "which kills 25,000 people every year," Agence France-Presse reports. The three-day summit was hosted by the NIH, CDC and PAHO, according to the news service.

19 Feb 2011

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has signed a licensing agreement with Biocare Medical, a biotechnology company based in Concord, Calif., for the exclusive worldwide sales and distribution rights for the immunohistochemistry of an antibody designed to detect tumor prevalence in prostate cancer patients.

18 Feb 2011

Impax' NDA for generic version of Adoxa receives final FDA approval

Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration has granted final approval of the Company's Abbreviated New Drug Application for its generic version of Adoxa.

18 Feb 2011

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Scientists in London are turning to sea sponges to help them learn more about anti-cancer drugs. Using his £106,079 grant from the Association for International Cancer Research Dr Matthew Fuchter and his team are investigating a naturally-occurring chemical found in the sea sponge.

18 Feb 2011

Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty

A rinsing technique with betadine that costs just a little over one dollar per patient may significantly reduce the infection rate following total knee and hip joint replacement surgery according to a study by researchers at Rush University Medical Center.

18 Feb 2011

Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns

The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm labor due to the potential for serious maternal heart problems and death. In addition, oral terbutaline tablets should not be used for prevention or treatment of preterm labor.

18 Feb 2011

China-Biotics applies 5 new patents for probiotics supplement, preparation

China-Biotics, Inc., the leading developer, manufacturer and distributor of probiotics products in China, today announced it has applied for 5 new patents through its wholly owned subsidiary Growing Bioengineering to the State Bureau of Intellectual Property.

18 Feb 2011

U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency

The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.

18 Feb 2011

Statin drug may help prevent blindness in diabetics

New University of Georgia research has found that a statin drug that is often known by the brand-name Lipitor may help prevent blindness in people with diabetes.

17 Feb 2011

Astellas' Protopic receives Health Canada approval for prevention of eczema flares

Astellas Pharma Canada, Inc. has announced that it has received approval from Health Canada for a new indication for its topical eczema therapy, Protopic® (tacrolimus ointment 0.03% and 0.1%). The new indication means that tacrolimus ointment can be prescribed for maintenance therapy to prevent flares and prolong flare free intervals in patients with moderate to severe atopic dermatitis (commonly called eczema).

17 Feb 2011

Iris Pharma announces validation of new EIU model of ocular inflammation

Iris Pharma, a world leader CRO specialized in ophthalmology, today announced the validation of the Endotoxin-Induced Uveitis model, a new model of ocular inflammation.

17 Feb 2011

Researchers develop new pneumococcal vaccine through novel discovery approach

Pneumococcus accounts for as much as 11 percent of mortality in young children worldwide. While successful vaccines like Prevnar exist, they are expensive and only work against specific pneumococcal strains, with the risk of becoming less effective as new strains emerge.

17 Feb 2011

Experts say signs and treatment of bacterial infection often misunderstood

According to the Canadian Foundation for Infectious Diseases, antibiotics are the second most frequently prescribed class of drugs - second only to pain relievers. Yet most people don't know the difference between a true bacterial infection, like chronic bronchitis that can be treated with antibiotics — and viruses like the common cold, which cannot.

17 Feb 2011

Spirulina Pacifica supplement may improve immune function, anemia in senior citizens

Cyanotech Corporation, world leader in microalgae-based health and nutrition supplements, announced today that researchers at the University of California at Davis have determined that microalgae-based Hawaiian Spirulina Pacifica may improve immune function and ameliorate anemia in persons over 50.

17 Feb 2011

EMA publishes concept paper on pharmaceutical cold storage conditions during transport

The European Medicines Agency has published a concept paper on storage conditions during transport. The goal is to create new Good Distribution Practice and GMP guidance and may lead to the need to revise the guideline on declaration of storage conditions.

From IQPC Ltd 17 Feb 2011

HHS unveils new National Vaccine Plan to enhance coordination of immunization activities

The U.S. Department of Health and Human Services today unveiled a new National Vaccine Plan to enhance coordination of all aspects of federal vaccine and immunization activities. Its goal is to ensure that all Americans can access the preventive benefits of vaccines.

17 Feb 2011

Pharmaceutical News

New study shows low doses of aspirin can significantly reduce risk of cancers

QRxPharma granted FDA pre-NDA meeting, further phase II data released

PBMI awards CVS Caremark and ArcelorMittal the 2011 Rx Benefit Innovation Award

Upsher-Smith expands voluntary recall of Jantoven Warfarin Sodium, 3 mg Tablets

U.S. scientists assess progress of dengue vaccine at 3-day summit in Puerto Rico

Biocare, HJF sign license agreement to distribute antibody against prostate cancer

Impax' NDA for generic version of Adoxa receives final FDA approval

Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs

Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty

Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns

China-Biotics applies 5 new patents for probiotics supplement, preparation

U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency

Statin drug may help prevent blindness in diabetics

Astellas' Protopic receives Health Canada approval for prevention of eczema flares

Iris Pharma announces validation of new EIU model of ocular inflammation

Researchers develop new pneumococcal vaccine through novel discovery approach

Experts say signs and treatment of bacterial infection often misunderstood

Spirulina Pacifica supplement may improve immune function, anemia in senior citizens

EMA publishes concept paper on pharmaceutical cold storage conditions during transport

HHS unveils new National Vaccine Plan to enhance coordination of immunization activities

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News